miltefosine
Selected indexed studies
- Miltefosine repositioning: A review of potential alternative antifungal therapy. (J Mycol Med, 2023) [PMID:37774486]
- Miltefosine reinvigorates exhausted T cells by targeting their bioenergetic state. (Cell Rep Med, 2024) [PMID:39657666]
- Miltefosine Treatment of Cutaneous Leishmaniasis. (Clin Infect Dis, 2021) [PMID:33128373]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Miltefosine repositioning: A review of potential alternative antifungal therapy. (2023) pubmed
- Miltefosine reinvigorates exhausted T cells by targeting their bioenergetic state. (2024) pubmed
- Miltefosine Treatment of Cutaneous Leishmaniasis. (2021) pubmed
- Miltefosine to treat leishmaniasis. (2005) pubmed
- Miltefosine and cutaneous leishmaniasis. (2012) pubmed
- Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis. (2012) pubmed
- Miltefosine: issues to be addressed in the future. (2006) pubmed
- No evidence for cardiotoxicity of miltefosine. (2022) pubmed
- Miltefosine: great expectations against visceral leishmaniasis. (2003) pubmed
- Ophthalmic adverse effects of miltefosine in the treatment of leishmaniasis: a systematic review. (2024) pubmed